1. Home
  2. HYFT vs CPHI Comparison

HYFT vs CPHI Comparison

Compare HYFT & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MindWalk Holdings Corp.

HYFT

MindWalk Holdings Corp.

HOLD

Current Price

$1.35

Market Cap

66.8M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.15

Market Cap

61.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFT
CPHI
Founded
1983
N/A
Country
United States
China
Employees
102
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
61.6M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
HYFT
CPHI
Price
$1.35
$1.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
240.9K
9.8M
Earning Date
03-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
$29.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$0.38
52 Week High
$3.00
$19.19

Technical Indicators

Market Signals
Indicator
HYFT
CPHI
Relative Strength Index (RSI) 47.08 48.70
Support Level $1.17 $0.84
Resistance Level $1.44 $1.22
Average True Range (ATR) 0.11 1.64
MACD -0.00 -0.14
Stochastic Oscillator 64.10 1.78

Price Performance

Historical Comparison
HYFT
CPHI

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: